Nektar Therapeutics is a biopharmaceutical company developing a pipeline of drug candidates designed to improve the benefits of existing drugs. Its product pipeline includes drug candidates across a number of therapeutic areas, including oncology, pain, anti-infectives, anti-viral and immunology. Nektar's research and development activities involve small molecule drugs, peptides and other potential biologic drug candidates. Simply put, Nektar's drugs optimize the performance of existing treatments by minimizing serious side effects.